Zyvox is exceptional, PhRMA says
The Pharmaceutical Research and Manufacturers of America offers its first Clinical Trial Exceptional Service Award to Donald Batts (Michigan State University), Sharon Nachman (Stony Brook University) and Maryam Imam, an 11 year-old volunteer patient on March 14. The two researchers helped make advances in clinical trials that led to the development of Pfizer's Zyvox (linezolid) for treatment of drug-resistant bacterial infections...
You may also be interested in...
Pfizer will not pursue an indication for catheter-related infections for Zyvox (linezolid) after data from a Phase III trial indicated an increased risk of death among patients with the infections treated with the oxazolidinone antibiotic
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.